LC
VERA icon

Lindbrook Capital’s Vera Therapeutics VERA Stock Holding History

Lindbrook Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$673 Buy
28
+16
+133% +$514 ﹤0.01% 2556
2024
Q4 		$507 Buy
+12
New +$531 ﹤0.01% 2619

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Lindbrook Capital's VERA Position: Q1 2025 in Review

Lindbrook Capital increased its Vera Therapeutics (VERA) stake by 133% in Q1 2025, buying an estimated $514 and bringing the position to 28 shares worth $673. The position accounts for ﹤0.01% of the portfolio, ranked #2556.

Lindbrook Capital first reported a position in VERA in Q4 2024 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold VERA as of Q1 2025.

  • Lindbrook Capital held 28 shares of Vera Therapeutics worth $673 as of Q1 2025.
  • Lindbrook Capital bought 16 Vera Therapeutics shares in Q1 2025, an estimated $514.
  • Vera Therapeutics made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2556 holding.
  • Lindbrook Capital first reported a position in Vera Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.